TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Spinal Muscular Atrophy (SMA) Drugs Market Insights, Forecast to 2028

Global Spinal Muscular Atrophy (SMA) Drugs Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 09 August 2022
  • Pages :73
  • Formats:
  • Report Code:SMR-7258180
OfferClick for best price

Best Price: $3920

Spinal Muscular Atrophy SMA Drugs Market Size, Share 2022


Market Analysis and Insights: Global Spinal Muscular Atrophy SMA Drugs Market

The global Spinal Muscular Atrophy SMA Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spinal Muscular Atrophy SMA Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spinal Muscular Atrophy SMA Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spinal Muscular Atrophy SMA Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spinal Muscular Atrophy SMA Drugs market.

Global Spinal Muscular Atrophy SMA Drugs Scope and Market Size

Spinal Muscular Atrophy (SMA) Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy (SMA) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Oral Medicine

Injection Medicine

Segment by Application

Baby

Child

Adult

By Company

Biogen

Novartis

Genentech

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Spinal Muscular Atrophy SMA Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Spinal Muscular Atrophy SMA Drugs, with price, sales, revenue, and global market share of Spinal Muscular Atrophy SMA Drugs from 2019 to 2022.

Chapter 3, the Spinal Muscular Atrophy SMA Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Spinal Muscular Atrophy SMA Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Spinal Muscular Atrophy SMA Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Spinal Muscular Atrophy SMA Drugs.

Chapter 13, 14, and 15, to describe Spinal Muscular Atrophy SMA Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Spinal Muscular Atrophy SMA Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Spinal Muscular Atrophy (SMA) Drugs Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 73 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy (SMA) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Medicine
1.2.3 Injection Medicine
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy (SMA) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Baby
1.3.3 Child
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy (SMA) Drugs Market Perspective (2017-2028)
2.2 Spinal Muscular Atrophy (SMA) Drugs Growth Trends by Region
2.2.1 Spinal Muscular Atrophy (SMA) Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Spinal Muscular Atrophy (SMA) Drugs Historic Market Size by Region (2017-2022)
2.2.3 Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Region (2023-2028)
2.3 Spinal Muscular Atrophy (SMA) Drugs Market Dynamics
2.3.1 Spinal Muscular Atrophy (SMA) Drugs Industry Trends
2.3.2 Spinal Muscular Atrophy (SMA) Drugs Market Drivers
2.3.3 Spinal Muscular Atrophy (SMA) Drugs Market Challenges
2.3.4 Spinal Muscular Atrophy (SMA) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy (SMA) Drugs Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy (SMA) Drugs Players by Revenue (2017-2022)
3.1.2 Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy (SMA) Drugs Revenue
3.4 Global Spinal Muscular Atrophy (SMA) Drugs Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy (SMA) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Drugs Revenue in 2021
3.5 Spinal Muscular Atrophy (SMA) Drugs Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy (SMA) Drugs Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy (SMA) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy (SMA) Drugs Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy (SMA) Drugs Historic Market Size by Type (2017-2022)
4.2 Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Type (2023-2028)
5 Spinal Muscular Atrophy (SMA) Drugs Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy (SMA) Drugs Historic Market Size by Application (2017-2022)
5.2 Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Spinal Muscular Atrophy (SMA) Drugs Market Size (2017-2028)
6.2 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type
6.2.1 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022)
6.2.2 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028)
6.2.3 North America Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2017-2028)
6.3 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application
6.3.1 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022)
6.3.2 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028)
6.3.3 North America Spinal Muscular Atrophy (SMA) Drugs Market Share by Application (2017-2028)
6.4 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country
6.4.1 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2017-2022)
6.4.2 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size (2017-2028)
7.2 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022)
7.2.2 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028)
7.2.3 Europe Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2017-2028)
7.3 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022)
7.3.2 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028)
7.3.3 Europe Spinal Muscular Atrophy (SMA) Drugs Market Share by Application (2017-2028)
7.4 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2017-2022)
7.4.2 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size (2017-2028)
8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type
8.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Application
8.3.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region
8.4.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size (2017-2028)
9.2 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type
9.2.1 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2017-2028)
9.3 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application
9.3.1 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Share by Application (2017-2028)
9.4 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country
9.4.1 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size (2017-2028)
10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type
10.2.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Application
10.3.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country
10.4.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Spinal Muscular Atrophy (SMA) Drugs Introduction
11.1.4 Biogen Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Spinal Muscular Atrophy (SMA) Drugs Introduction
11.2.4 Novartis Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Genentech
11.3.1 Genentech Company Details
11.3.2 Genentech Business Overview
11.3.3 Genentech Spinal Muscular Atrophy (SMA) Drugs Introduction
11.3.4 Genentech Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022)
11.3.5 Genentech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Spinal Muscular Atrophy (SMA) Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral Medicine
Table 3. Key Players of Injection Medicine
Table 4. Global Spinal Muscular Atrophy (SMA) Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Region (2017-2022)
Table 8. Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Region (2023-2028)
Table 10. Spinal Muscular Atrophy (SMA) Drugs Market Trends
Table 11. Spinal Muscular Atrophy (SMA) Drugs Market Drivers
Table 12. Spinal Muscular Atrophy (SMA) Drugs Market Challenges
Table 13. Spinal Muscular Atrophy (SMA) Drugs Market Restraints
Table 14. Global Spinal Muscular Atrophy (SMA) Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Share by Players (2017-2022)
Table 16. Global Top Spinal Muscular Atrophy (SMA) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Drugs as of 2021)
Table 17. Ranking of Global Top Spinal Muscular Atrophy (SMA) Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Spinal Muscular Atrophy (SMA) Drugs Product Solution and Service
Table 21. Date of Enter into Spinal Muscular Atrophy (SMA) Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by Type (2017-2022)
Table 25. Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by Type (2023-2028)
Table 27. Global Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Share by Application (2017-2022)
Table 29. Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Share by Application (2023-2028)
Table 31. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 61. Biogen Company Details
Table 62. Biogen Business Overview
Table 63. Biogen Spinal Muscular Atrophy (SMA) Drugs Product
Table 64. Biogen Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022) & (US$ Million)
Table 65. Biogen Recent Developments
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Spinal Muscular Atrophy (SMA) Drugs Product
Table 69. Novartis Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022) & (US$ Million)
Table 70. Novartis Recent Developments
Table 71. Genentech Company Details
Table 72. Genentech Business Overview
Table 73. Genentech Spinal Muscular Atrophy (SMA) Drugs Product
Table 74. Genentech Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022) & (US$ Million)
Table 75. Genentech Recent Developments
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Type: 2021 VS 2028
Figure 2. Oral Medicine Features
Figure 3. Injection Medicine Features
Figure 4. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Application: 2021 VS 2028
Figure 5. Baby Case Studies
Figure 6. Child Case Studies
Figure 7. Adult Case Studies
Figure 8. Spinal Muscular Atrophy (SMA) Drugs Report Years Considered
Figure 9. Global Spinal Muscular Atrophy (SMA) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Spinal Muscular Atrophy (SMA) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Region: 2021 VS 2028
Figure 12. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Players in 2021
Figure 13. Global Top Spinal Muscular Atrophy (SMA) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Drugs as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Drugs Revenue in 2021
Figure 15. North America Spinal Muscular Atrophy (SMA) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Type (2017-2028)
Figure 17. North America Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Application (2017-2028)
Figure 18. North America Spinal Muscular Atrophy (SMA) Drugs Market Size Share by Country (2017-2028)
Figure 19. United States Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Type (2017-2028)
Figure 23. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Application (2017-2028)
Figure 24. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size Share by Country (2017-2028)
Figure 25. Germany Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size Share by Region (2017-2028)
Figure 35. China Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size Share by Country (2017-2028)
Figure 45. Mexico Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Spinal Muscular Atrophy (SMA) Drugs Market Size Share by Country (2017-2028)
Figure 51. Turkey Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Biogen Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022)
Figure 55. Novartis Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022)
Figure 56. Genentech Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Drugs Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount